Recursion Pharmaceuticals, Inc.

RXRX·NASDAQ·$2.97Share Price as of 11/2·$1BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2605/06/26 10-KFY 202502/25/26 10-QQ3 ended 09/30/2511/05/25 10-QQ2 ended 06/30/2508/05/25

Disclosures

8-KCurrent report10/15/26 8-KEntry into Material Agreement09/21/26 8-KResults of Operations; Regulation FD Disclosure08/05/26 8-KCurrent report06/18/26 8-KResults of Operations; Regulation FD Disclosure05/06/26

Prospectuses and Registrations

424B5Prospectus supplement10/15/26 424B5Prospectus supplement10/15/26 424B5Prospectus supplement02/25/26 S-8Registration of securities for employees02/25/26 424B7Prospectus11/26/25

Proxies

DEF 14ADefinitive proxy04/30/26 DEFA14AAdditional proxy materials04/30/26 DEF 14ADefinitive proxy04/28/25 DEFA14AAdditional proxy materials04/28/25 DEFA14AAdditional proxy materials11/06/24

Ownership

Form 4Insider transaction10/07/26 Form 4Insider transaction10/07/26 144Proposed sale of securities10/06/26 144Proposed sale of securities10/06/26 Form 4Insider transaction10/02/26

Other

ARSAnnual report to shareholders04/30/26 ARSAnnual report to shareholders04/28/25 CORRESPCorrespondence with the SEC06/13/24 UPLOADLetter from the SEC06/13/24 UPLOADLetter from the SEC05/30/24